Skip to main content
Psomagen, Inc. logo

Psomagen, Inc. — Investor Relations & Filings

Ticker · 950200 ISIN · KR8840150005 KO Professional, scientific and technical activities
Open in API
Filings indexed 180 across all filing types
Latest filing 2025-03-31 Declaration of Voting R…
Country US United States of America
Listing KO 950200

About Psomagen, Inc.

https://www.psomagen.com/

Psomagen, Inc. is a contract laboratory service provider specializing in multiomics and data analysis solutions for scientists and clinicians. Operating from CLIA-certified and CAP-accredited facilities, the company offers a comprehensive suite of services to the academic, clinical, and life sciences research communities. Its core offerings encompass genomics, epigenomics, proteomics, transcriptomics, and metagenomics. Psomagen utilizes a range of sequencing technologies, including Sanger sequencing, Next-Generation Sequencing (NGS), and third-generation sequencing. The company also provides specialized solutions such as spatial biology analysis, cell line authentication via STR profiling, and advanced bioinformatics support to analyze complex biological data.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting, including financial statement approval, director appointments, and dividend status. This document is an official record of the voting outcomes from a general meeting, which directly aligns with the definition for 'Declaration of Voting Results & Voting Rights Announcements'.
2025-03-31 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 100% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the appointment or dismissal of outside directors (사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고). This falls under the category of board and management changes, which is classified as MANG.
2025-03-31 Korean
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report) submitted by Somagen. It contains detailed financial tables, audit opinions, and financial statements for the fiscal year. While it provides financial data, it is a standard regulatory disclosure announcement regarding the receipt and submission of the audit report to the exchange (KRX), rather than the full, multi-page annual report document itself. Following the 'Menu vs Meal' rule, this is a formal announcement of the report's availability and key summary figures, which falls under the category of a Report Publication Announcement. FY 2024
2025-03-21 Korean
사업보고서 (2024.12)
Annual Report Classification · 100% confidence The document is a '사업보고서' (Business Report) for the fiscal year 2024 (Jan 1, 2024 - Dec 31, 2024) filed by Psomagen, Inc. with the Financial Supervisory Service (FSS) of South Korea. It contains comprehensive sections including company overview, business details, financial statements, management discussion and analysis, and governance information. This structure corresponds to the standard Korean Annual Report (10-K equivalent). FY 2024
2025-03-21 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Correction Report' (정정신고) regarding a 'Notice of Convocation of Annual General Meeting' (주주총회소집공고). It contains updated financial statements (balance sheets, income statements, etc.) that were revised following an external audit. Since the primary purpose of this filing is to provide updated materials for the upcoming Annual General Meeting (AGM), it falls under the category of AGM-related materials.
2025-03-21 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Somagen. It outlines the date, location, and agenda items for the upcoming Annual General Meeting (AGM), including the approval of financial statements, election of directors, and remuneration limits. This document serves as the official proxy solicitation and meeting notice provided to shareholders to inform them of the meeting and request their participation/votes. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2025-03-14 Korean

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.